Essure hysteroscopic sterilization versus interval laparoscopic bilateral tubal ligation: a comparative effectiveness review.
A comparative effectiveness analysis was performed to examine the risks and benefits of laparoscopic bilateral tubal ligation compared with hysteroscopic sterilization using the Essure Permanent Birth Control System (Bayer HealthCare AG, Whippany, NJ). Existing evidence shows that both LBTL and Essure are safe and effective methods of female sterilization. Both have high rates of efficacy and low rates of complications although when complications do occur, those related to the Essure procedure are more likely to be minor in nature. The analysis was limited by the restricted number of studies involving head-to-head comparisons of the 2 approaches.
['Ouzounelli|Myrsini|M|', 'Reaven|Nancy L|NL|']
D057186:Comparative Effectiveness Research D005187:Fallopian Tubes D005260:Female D006801:Humans D015907:Hysteroscopy D010535:Laparoscopy D019964:Mood Disorders D009325:Nausea D010149:Pain, Postoperative D011247:Pregnancy D011271:Pregnancy, Ectopic D016032:Randomized Controlled Trials as Topic D018570:Risk Assessment D013246:Sterilization, Tubal D016896:Treatment Outcome
Essure Hysteroscopic sterilization Laparoscopic Tubal ligation